The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $84.43

Today's change+0.36 +0.43%
Updated February 24 4:02 PM EST. Delayed by at least 15 minutes.
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $84.43

Today's change+0.36 +0.43%
Updated February 24 4:02 PM EST. Delayed by at least 15 minutes.

Perrigo Company PLC up (U.S.)$0.36

Perrigo Company PLC closed up Friday by (U.S.)$0.36 or 0.43% to (U.S.)$84.43. This security is unchanged over the last five days and the last 52 weeks. This security has underperformed the S&P 500 by 55.80% during the last year.

Key company metrics

  • Open(U.S.) $84.37
  • Previous close(U.S.) $84.07
  • High(U.S.) $84.80
  • Low(U.S.) $83.07
  • Bid / Ask-- / --
  • YTD % change+1.44%
  • Volume1,284,171
  • Average volume (10-day)1,418,356
  • Average volume (1-month)1,856,721
  • Average volume (3-month)1,732,269
  • 52-week range(U.S.) $71.84 to (U.S.) $140.65
  • Beta0.75
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward12.15×
  • Forward PEG2.89×
  • Indicated annual dividend(U.S.) $0.64
  • Dividend yield0.76%
  • Trailing EPS(U.S.) -$10.47
Updated February 24 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-26.62%

Perrigo Company PLC has a net profit margin of -26.62%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX1.57%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016Dec 31, 201512/31/2015
Revenue1,3551,4811,3832,770
Total other revenue--------
Total revenue1,3551,4811,3832,770
Gross profit5065675231,108
Total cost of revenue8499148601,661
Total operating expense2,8711,2431,6872,676
Selling / general / administrative285296309683
Research & development50474588
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1,687-14473243
Other operating expenses, total--------
Operating income-1,516238-30494
Interest income (expense), net non-operating-------89
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,572152-359-23
Income after tax-1,255194-3356
Income tax, total-316-43-25-29
Net income-1,255194-3356
Total adjustments to net income0------
Net income before extra. items-1,255194-3356
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1,255194-3356
Inc. avail. to common incl. extra. items-1,255194-3356
Diluted net income-1,255194-3356
Dilution adjustment00--0
Diluted weighted average shares143144143146
Diluted EPS excluding extraordinary itemsvalue per share-8.761.35-2.340.04
Dividends per sharevalue per share0.150.150.150.13
Diluted normalized EPSvalue per share-1.111.29-0.191.12